Moderna’s Covid Vaccine Receives Full Approval From U.S. FDA

preview_player
Показать описание
Moderna Inc.’s vaccine for Covid-19 received full approval from the U.S. Food and Drug Administration for people 18 and older, an important milestone that bolsters the shot’s use as a major weapon against the virus.

The vaccine, which goes by the brand name Spikevax, had previously been available to adults in the U.S. under an emergency use authorization from the FDA. But the full clearance lets Moderna market the vaccine to adults with the full imprimatur of the FDA.

Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.

Connect with us on…
Рекомендации по теме
Комментарии
Автор

So can we sue them if it hurts us now?

TheScyth
Автор

le vaccin moderna le plus efficace du monde contre le COVID, bravo et félicitations le vaccin moderna, un grand merci le vaccin moderna.

esthersunda